Inhaling Hydrogen Ameliorates Early Postresuscitation EEG Characteristics in an Asphyxial Cardiac Arrest Rat Model.
Gang Chen, Jingru Li, Jianjie Wang, Bihua Chen, Yongqin Li · BioMed research international · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In this asphyxial CA rat model, the improved postresuscitation EEG characteristics for animals treated with hydrogen are correlated with the better 96 h neurological outcome and predicted survival. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in female Sprague-Dawley rats. In this asphyxial CA rat model, the improved postresuscitation EEG characteristics for animals treated with hydrogen are correlated with the better 96 h neurological outcome and predicted survival.
What the Researchers Studied
The researchers studied female Sprague-Dawley rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Immediately following ROSC, animals were assigned to the H₂ group or Ctrl group (each n = 20) according to random number table method. in the H₂ group, animals were ventilated with 2% hydrogen plus 98% oxygen. Animals in the experimental group were ventilated mechanically for 1 hour with a mixture of 2% hydrogen and 98% oxygen, then for 3 hours with air, while animals in the control group were ventilated for 1 hour with a mixture of 2% nitrogen and 98% oxygen, and then for 3 hours with air. In this asphyxial CA rat model, the improved postresuscitation EEG characteristics for animals treated with hydrogen are correlated with the better 96 h neurological outcome and predicted survival.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was female Sprague-Dawley rats. The reported sample size was 40. The study used a preclinical animal experiment.
Limitations and Safety
Safety information: Tomoyoshi et al. examined the feasibility and safety of hydrogen gas inhalation for human patients with post-CA syndrome [ 28 ].
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.